Advertisement
Advertisement
BIO
Bio-Rad Laboratories, Inc.Class A
380.12
USDSponsored
-5.99
-1.55%
Sep 08, 15:59 UTC -4
Closed
After-Market
380.06
-0.06
-0.01%
BIO Earnings Reports
Positive Surprise Ratio
BIO beat 30 of 43 last estimates.
70%
Next Report
Date of Next Report
Oct 27, 2026
Estimate for Q3 26 (Revenue/ EPS)
$657.15M
/$2.25
Implied change from Q2 26 (Revenue/ EPS)
+0.95%
/-14.12%
Implied change from Q3 25 (Revenue/ EPS)
+0.64%
/--
Bio-Rad Laboratories, Inc.Class A earnings per share and revenue
On Aug 04, 2026, BIO reported earnings of 2.62 USD per share (EPS) for Q2 26, beating the estimate of 1.76 USD, resulting in a 48.43% surprise. Revenue reached 651.00 million, compared to an expected 630.23 million, with a 3.30% difference. The market reacted with a +4.50% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 6 analysts forecast an EPS of 2.25 USD, with revenue projected to reach 657.15 million USD, implying an decrease of -14.12% EPS, and increase of 0.95% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Medtronic plc
Report Date
Sep 01, 2026 For Q1 27
Estimate
$1.40
Actual
$1.45
Surprise
+3.45%
Agilent Technologies Inc.
Report Date
Aug 26, 2026 For Q3 26
Estimate
$1.51
Actual
$1.62
Surprise
+6.90%
Phibro Animal Health Corporation Class A
Report Date
Aug 26, 2026 For Q4 26
Estimate
$0.72
Actual
$0.85
Surprise
+16.87%
FAQ
What were Bio-Rad Laboratories, Inc.Class A's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Bio-Rad Laboratories, Inc.Class A reported EPS of $2.62, beating estimates by 48.43%, and revenue of $651.00M, 3.3% above expectations.
How did the market react to Bio-Rad Laboratories, Inc.Class A's Q2 2026 earnings?
The stock price moved up 4.5%, changed from $332.88 before the earnings release to $347.86 the day after.
When is Bio-Rad Laboratories, Inc.Class A expected to report next?
The next earning report is scheduled for Oct 27, 2026.
What are the forecasts for Bio-Rad Laboratories, Inc.Class A's next earnings report?
Based on 6
analysts, Bio-Rad Laboratories, Inc.Class A is expected to report EPS of $2.25 and revenue of $657.15M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement